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Abstract: Infection of humans by the larval stage of the tapeworms Echinococcus granulosus sensu lato or
Echinococcus multilocularis causes the life-threatening zoonoses cystic echinococcosis (CE) and alveolar
echinococcosis (AE). Although cystic liver lesions are a hallmark of both diseases, course, prognosis,
and patients’ management decisively differ between the two. The wide and overlapping spectrum of
morphologies and the limited availability of ancillary tools are challenges for pathologists to reliably
diagnose and subtype echinococcosis. Here, we systematically and quantitatively recorded the pathologic
spectrum in a clinically and molecularly defined echinococcosis cohort (138 specimens from 112 patients).
Immunohistochemistry using a novel monoclonal antibody (mAbEmG3) was implemented, including its
combined application with the mAbEm2G11. Six morphologic criteria sufficiently discriminated between
CE and AE: size of smallest (CE/AE: >2/฀2 mm) and largest cyst (CE/AE: >25/฀25 mm), thickness
of laminated layer (CE/AE: >0.15/฀0.15 mm) and pericystic fibrosis (CE/AE: >0.6/฀0.6 mm), striation
of laminated layer (CE/AE: moderate-strong/weak), and number of cysts (CE/AE: ฀9/>9). Combined
immunohistochemistry with mAbEm2G11 (E. multilocularis specific) and mAbEmG3 (reactive in AE and
CE) was equally specific as and occasionally more sensitive than polymerase chain reaction. On the basis
of these findings, we developed a diagnostic algorithm for the differential diagnosis of echinococcosis.
In summary, we have not only identified the means to diagnose echinococcosis with greater certainty,
but also defined morphologic criteria, which robustly discriminate between CE and AE. We expect our
findings to improve echinococcosis diagnostics, especially of challenging cases, beneficially impacting the
management of echinococcosis patients.
DOI: https://doi.org/10.1097/pas.0000000000001374





Reinehr, Michael; Micheloud, Charlotte; Grimm, Felix; Kronenberg, Philipp A; Grimm, Johannes; Beck,
Annika; Nell, Juliane; Meyer zu Schwabedissen, Cordula; Furrer, Eva; Müllhaupt, Beat; Barth, Thomas











































A Morphologic and Immunohistochemical Study on 138 Specimens With
Focus on the Differential Diagnosis Between Cystic and Alveolar
Echinococcosis
Michael Reinehr,* Charlotte Micheloud,† Felix Grimm, PhD,‡ Philipp A. Kronenberg, MSc,‡§
Johannes Grimm,∥ Annika Beck, MD,∥ Juliane Nell,∥ Cordula Meyer zu Schwabedissen, MD,¶
Eva Furrer, PhD,† Beat Müllhaupt, MD,¶ Thomas F.E. Barth, MD,∥ Peter Deplazes, DVM,‡
and Achim Weber, MD*#
Abstract: Infection of humans by the larval stage of the tapeworms
Echinococcus granulosus sensu lato or Echinococcus multilocularis
causes the life-threatening zoonoses cystic echinococcosis (CE) and
alveolar echinococcosis (AE). Although cystic liver lesions are a
hallmark of both diseases, course, prognosis, and patients’ man-
agement decisively differ between the two. The wide and over-
lapping spectrum of morphologies and the limited availability of
ancillary tools are challenges for pathologists to reliably diagnose
and subtype echinococcosis. Here, we systematically and quantita-
tively recorded the pathologic spectrum in a clinically and molec-
ularly defined echinococcosis cohort (138 specimens from 112
patients). Immunohistochemistry using a novel monoclonal
antibody (mAbEmG3) was implemented, including its combined
application with the mAbEm2G11. Six morphologic criteria suffi-
ciently discriminated between CE and AE: size of smallest (CE/AE:
>2/≤2mm) and largest cyst (CE/AE: >25/≤25mm), thickness of
laminated layer (CE/AE: >0.15/≤0.15mm) and pericystic fibrosis
(CE/AE: >0.6/≤0.6mm), striation of laminated layer (CE/AE:
moderate-strong/weak), and number of cysts (CE/AE: ≤ 9/>9).
Combined immunohistochemistry with mAbEm2G11 (E. multi-
locularis specific) and mAbEmG3 (reactive in AE and CE) was
equally specific as and occasionally more sensitive than polymerase
chain reaction. On the basis of these findings, we developed a di-
agnostic algorithm for the differential diagnosis of echinococcosis.
In summary, we have not only identified the means to diagnose
echinococcosis with greater certainty, but also defined morphologic
criteria, which robustly discriminate between CE and AE. We ex-
pect our findings to improve echinococcosis diagnostics, especially
of challenging cases, beneficially impacting the management of
echinococcosis patients.
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W ith > 1 million people infected worldwide, echino-coccosis is a globally occurring parasitic disease with
a significant health burden.1,2 It is listed among the ne-
glected tropical diseases recognized by the World Health
Organization.3 Echinococcosis is more prevalent in rural
areas, in particular, of resource-poor countries, but, re-
cently, shifting more and more into urban areas.4 Local
transmission is also well documented in North America
including the United States, with an increase in incidence
observed, especially for alveolar echinococcosis (AE), not
only in the United States but also in Central Europe.5–7
Hence, there is increasing awareness of echinococcosis as a
potentially emerging threat to humans in rural and in in-
ner-city areas all over the world.
Humans are infected by the eggs of Echinococcus spp.
when exposed to infected definitive hosts (eggs on animal
hair), via the contaminated environment (hands-mouth
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transmission), or by consuming contaminated food (vegeta-
bles, water),8 and present a dead end for the parasitic in-
fection cycle. Echinococcosis is a disease caused by different
Echinococcus spp., manifesting either in a cystic, polycystic,
or alveolar form.9 Cystic echinococcosis (CE; alias uni-
locular echinococcosis) is caused by the larval (metacestode)
stage of Echinococcus granulosus sensu lato (referred in this
paper as E. granulosus), AE (alias alveolar hydatid disease or
multilocular echinococcosis) is caused by Echinococcus
multilocularis, and polycystic echinococcosis (alias polycystic
hydatid disease or neotropical echinococcosis) by Echino-
coccus vogeli or Echinococcus oligarthra, both of which only
rarely affect humans. In echinococcosis, liver and less fre-
quently lungs are primarily affected, but manifestations of
the disease can occur in virtually any organ system.10
The clinical presentation of echinococcosis in humans
ranges from asymptomatic to severe disease depending on the
location and species of parasites and stage of the disease.10
Although an expansive growth is typical for CE, AE is char-
acterized by an infiltrative, cancer-like growth, frequently in-
vading and destroying tissue, with extension beyond organ
borders or distant spread. Mainly due to this aggressive
growth, AE may take a fatal course.9 The diagnosis of echi-
nococcosis is usually made in a multimodal approach, taking
advantage of a combination of imaging techniques including
ultrasonography, magnetic resonance imaging, and computed
tomography scans,11,12 and serologic tests such as enzyme-
linked immunosorbent assay (ELISA) and Western blotting.
Confirmation of probable cases, as defined by the World
Health Organization,13 can be achieved by nucleic acid–based
analysis (polymerase chain reaction [PCR]/sequencing) or by
histopathologic analysis of tissue samples (biopsy, surgical
material, autopsy, and fine-needle aspirates).14,15 Currently
available serologic tests for AE reach high sensitivity and
specificity with clinical samples from European patients;
however, even a combination of several tests showed strongly
reduced sensitivities dependent on the stage of AE and were
greatly reduced in early and very small lesions.16 Finally, his-
topathology, occasionally supplemented with DNA analyses
and/or immunohistochemistry (IHC) if available, is the gold
standard of diagnosis.17,18
Pathologists are faced with tissue specimen con-
taining the metacestode stage of Echinococcus spp. not
only in cases clinically suspicious of echinococcosis, but
also in cases of liver lesions suspicious of a neoplastic le-
sion. The literature on the histopathology of echino-
coccosis includes articles and textbook chapters involving
histopathology, among other topics. Although the main
features are listed, a rigorous comparison is still lacking.
In addition, several comments on specific characteristics
do not withstand our observations in daily diagnostics—
for example, the notion that protoscolices are not ob-
servable in AE.4,17,19,20 This imprecision can lead to sub-
stantial uncertainty of diagnosis, possibly preventing the
correct subclassification of echinococcosis.
This prompted us to systematically and compre-
hensively analyze the histopathology of echinococcosis with
the aim to define differential criteria. Furthermore, we tested
the informative value of two monoclonal antibodies (mAbs)
produced against E. multilocularis metacestode antigens for
application in daily pathology practice.
MATERIALS AND METHODS
Samples were identified from the archives of the
Department of Pathology and Molecular Pathology,
University Hospital Zurich (USZ), between 1997 and
2018. All cases were reevaluated for this study. Clinical
information was retrieved from the USZ Echinococcus
register. This study was reviewed and approved by the
internal review board of the University Hospital Zurich
and the Cantonal Ethics Committee of Zurich, Switzerland
(KEK-ZH-Nr. 2015-0498).
Antibody Production
Two immunohistochemical stainings (IHC-S) were
applied in this study as a screening strategy for infection
with Echinococcus spp. The first IHC-S with the im-
munoglobulin (Ig) G1 mAbEm2G11 was directed against
a mucin-type Em2 glycoprotein specific for E. multi-
locularis.17,21,22 The second IHC-S with the IgM mAb-
EmG3 was directed against an antigen, which has not
been characterized yet. Both mAbs are in vitro produced
mAbs from a mouse hybridoma cell line, as described in
detail.22 The mAbEmG3 was produced in the same fusion
as the mAbEm2G11, but was not further used because
of cross-reactivity to E. granulosus metacestode antigens.
For this study, both antibodies have been reevaluated for
their specificity against a panel of helminths’ antigens
(for details, see Supplement 1—Table, Supplemental Digital
Content 1, http://links.lww.com/PAS/A841).
Characterization of the Specificity of the mAbs
mAbEm2G11 and mAbEmG3 in ELISA Using
Native Echinococcus spp. and Antigens of Other
Helminths
ELISA was performed in principal, as described by
Schweiger et al14 mAb were produced in vitro by hy-
bridoma cell cultivation. Supernatants containing the
mAbs were added in a dilution of 1:2 in ELISA buffer
(PBS [pH 7.2] containing 0.02% [wt/vol] NaN3, 0.05%
[wt/vol] bovine hemoglobin, and 0.3% [v/v] Tween-20
[PBS-T]). Mouse serum of an experimentally infected an-
imal with AE was diluted 1:100. Anti-mouse IgG (whole
molecule)-alkaline phosphatase conjugate (Sigma-Aldrich,
A3562) was used in a dilution of 1:10,000 in PBS-T.
ELISA substrate readout was performed after 20 minutes
at 405 nm (OD405) with a reference wavelength of 630
nm. The mAbDi36/1, directed to Dirofilaria immitis and
Dirofilaria repens adult somatic and E/S antigens,23 was
used as a negative control antibody for Echinococcus spp.
epitopes. Native Echinococcus spp. antigens were pre-
pared, as previously described.14 Antigens of other hel-
minths were prepared, as described by Deplazes and
Gottstein.22 The mouse serum from a BALB/c mouse in-
fected with 500 viable eggs of E. multilocularis with liver
AE was used for the documentation of the antigenicity of
the antigens applied (animal experiment authorized by the
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Cantonal Veterinary Office of Zurich, Switzerland (per-
mission no. 294/2014)).
The mAbEmG3 and the mAbEm2G11 are available
on request from Peter Deplazes at the Institute of Para-
sitology, University of Zurich, Switzerland.
Histology, Histochemical Stains, IHC, and
Imaging
Histologic, histochemical, and IHC-S and digitalization
for virtual microscopy were performed, as previously de-
scribed with slight modifications.24,25 Briefly, tissues were fixed
in 4% paraformaldehyde and paraffin embedded. Tissue sec-
tions (2 to 3 μm thickness) were stained with hematoxylin and
eosin (H&E), elastica van Gieson, periodic acid-Schiff, or with
mAbEmG3 or characterization of the mAbEm2G11. Im-
munohistochemical staining with both mAbs comprised 30
minutes pretreatment at 100°C with TrisEDTA borat (pH
9.0), dilution 1:200 (mAbEm2G11) and 1:1000 (mAbEmG3),
respectively, incubation for 30 minutes (Leica Bond-III), and
detection with Bond Polymer Refine Detection Kit. Histologic
and IHC slides were digitalized for virtual microscopy, ar-
chiving, and image preparation for figures, using a Nano
Zoomer C9600 Virtual Slide Light microscope scanner by
Hamamatsu using NDP, View Software.
Genetic Analyses
Species-specific PCRs targeting the mitochondrial
12S rRNA gene were performed on DNA isolated from
FFPE tissue samples according to Stieger et al26 for E.
multilocularis and according to Stefanic et al,27 or—if the
first PCR was negative—according to Trachsel et al28 for
E. granulosus. Amplicons were sequenced by a private
company service (Synergene Biotech GmbH, Schlieren,
Switzerland).
Statistical Analyses
To assess the agreement of IHC-S and PCR (gold
standard) for discrimination of Echinococcus spp., the cal-
culation of Cohen κ was recommended.29 As this calcu-
lation was not possible due to perfect agreement, we relied
on a simulation approach to assess how likely perfect
agreement is in different scenarios. For the continuous
morphologic criteria, receiver operating characteristic
(ROC) curves were plotted, and the area under the curve
was calculated as a measure for the discriminative power of
the criteria between an infection with E. multilocularis and
an infection with E. granulosus. Higher area under the
curves indicate better diagnostic power.30 Optimal cutpoints
were determined from the ROC curve by maximization of
the sum of sensitivity and specificity. For the binary mor-
phologic criteria, sensitivity and specificity were calculated
as measures for the discriminative power between CE and
AE. A criterion having both specificity and sensitivity
> 0.85 was considered a good diagnostic test. For defining a
diagnostic algorithm, a random forest based on all criteria
was calculated.31 This allowed to quantify each criterion’s
importance by how much the classification of specimens to
AE and CE loses in prediction accuracy if a single criterion is
removed from the model.31 Prediction accuracy was estimated
through cross-validation within the present cohort, for ex-
ample, leaving one observation out of the estimation step
and then predicting its classification. Using a subset of good
diagnostic criteria, the optimal decision tree was then
determined by recursive partitioning.32 All statistical analyses
were conducted with R (version 3.4.2),33 and the packages
rpart,34 randomForest,35 pROC,36 ROCR,37 reporttools,38
ggplot2,39 partykit,40 ggparty,41 and OptimalCutpoints.42
RESULTS
A total of 138 formalin-fixed, paraffin-embedded
(FFPE) tissue specimens from 112 patients analyzed at the
Department of Pathology and Molecular Pathology, USZ,
between 1997 and 2018, were included in this study
(Table 1). Given the not definitively subtyped cases of
echinococcosis based on clinical data and serology, we first
aimed to perform genetic testing in a subset of FFPE
echinococcosis specimens to definitively classify these. To
this aim, PCR was performed on 48 FFPE tissue samples, of
which 42 were informative. On the basis of PCR results, 24
cases were unequivocally classified as AE, and 18 as CE.
We next aimed to test the informative value of IHC
for the detection and differentiation of Echinococcus spp. in
FFPE tissues. In addition to the mAbEm2G11, well es-
tablished for IHC-S,17 we applied the hitherto unpublished
mAbEmG3, reacting with epitopes of larval stages of both
E. multilocularis and E. granulosus (for validation, see
Supplement 1—Table, Supplemental Digital Content 1,
http://links.lww.com/PAS/A841). IHC-S was first applid
to representative specimens of patients with AE and CE,
respectively (Fig. 1).
The mAbEmG3 labeled parasitic material including
the laminated layer (LL), germinal layer (GL), rostellum,
and sheath of the protoscolices of both E. granulosus and
E. multilocularis. Staining patterns of the mAbEm2G11 re-
vealed a strong reactivity with the LL, but not with proto-
scolices of E. multilocularis; no staining was documented








Men 22 (37.3) 32 (60.4)







Liver 55 (93.2) 45 (84.9)
Lung 2 (3.4) 0
Soft tissue 1 (1.7) 7 (13.2)
Other 1 (gall bladder) (1.7) 1 (peritoneum) (1.9)
Main clinicopathologic features of echinococcosis cohort cases.
*P< 0.0001 (unpaired 2-tailed t test).
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FIGURE 1. IHC for the detection of Echinococcus spp. A and B, Histomorphology. Typical parasitic material found inside the
metacestodes of Echinococcus granulosus (A) and Echinococcus multilocularis (B) including LLs (black arrowhead), protoscolices
(brood capsule marked with white arrowheads), and the GL (asterisk in A). C and D, IHC-S mAbEmG3. The antibody mAbEmG3
stains parasitic material of both E. granulosus (C) and E. multilocularis (D). Moreover, debris of decayed parasite material is stained in
the cyst’s surrounding (so-called “SPEMS”) (D). E and F, IHC-S mAbEm2G11. Staining patterns of the mAbEm2G11 showing strong
reactivity with metacestodes of E. multilocularis (F), but negativity in E. granulosusmetacestodes (E). In contrast to the mAbEm2G11
(F), the mAbEmG3 notably also stains rostellum and tegument of the protoscolex (D). Scale bars (in A–F): 1mm; insets: 100 μm.
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using metacestode material from patients with CE. Simul-
taneous reactivity with both mAbs was regarded as diag-
nostic for AE, while positivity only for the mAbEmG3 was
regarded as diagnostic of CE. Thus, the mAbEmG3 has its
value also in confirming the diagnosis of echinococcosis in
lesions without any diagnostic morphology (eg, in fine-needle
aspirates, necrotic debris, completely fibrotic lesions).
Next, we aimed to evaluate the specificity of its IHC
reactivity by testing tissues other than from CE and AE pa-
tients with the mAbs. To this aim, tissue of a patient with an E.
vogeli metacestode infection43 was incubated with both anti-
bodies. The mAbEmG3 showed an intense staining of the GL,
sheath, and rostellum of the protoscolices and weak staining of
the LL; no positive staining with the mAbEm2G11 was found
(Supplement 2—Fig., Supplemental Digital Content 2, http://
links.lww.com/PAS/A842). Thus, the IHC-S pattern re-
capitulated the one observed for E. granulosus metacestode
tissue, but displayed a slightly weaker staining of the LL of E.
vogeli. Moreover, 4 different nonechinoccocal helminths were
investigated with both antibodies (Supplement 3—Fig., Sup-
plemental Digital Content 3, http://links.lww.com/PAS/A843).
Furthermore, tissues of granulomatous reactions not related to
echinococcosis were also incubated with both antibodies
(Supplement 4—Fig., Supplemental Digital Content 4, http://
links.lww.com/PAS/A844). None of these incubations resulted
in any positive stain (or even faint cross-reaction). On the basis
of the above-described staining patterns, we regarded the
mAbEmG3 to be specific for Echinococcus spp.
Taking advantage of the 42 genetically confirmed
AE or CE cases, we next aimed to determine the sensitivity
and specificity of immunostaining for the detection of
Echinococcus spp. in FFPE tissues. We found that all 24
cases previously diagnosed as AE by PCR, consistently
revealed a double-positive IHC-S pattern, that is, mAb-
EmG3(+)/mAbEm2G11(+), whereas all 18 cases pre-
viously identified as CE by PCR, showed the combination
of mAbEmG3(+)/mAbEm2G11(−). In summary, the 42
cases revealed 100% accordance between PCR testing and
IHC (Fig. 1, Supplement 5A—Fig., Supplemental Digital
Content 5, http://links.lww.com/PAS/A845). Because of
this complete agreement, it formally was not possible to
determine Cohen’s κ. Statistical simulation of 500 agree-
ment tables revealed that the perfect agreement of the two
diagnostic methods is very unlikely to occur by chance
(Supplement 5B—Fig., Supplemental Digital Content 5,
http://links.lww.com/PAS/A845). Therefore, IHC was
considered as powerful as PCR testing for the discrim-
ination between CE and AE.
Given that molecular testing and/or IHC for echino-
coccosis are not universally available in all pathology labo-
ratories, time-consuming, and expensive, we next sought to
test the diagnostic power of an evaluation purely based on
morphology. To this aim, cases were assigned to either AE
or CE, respectively. On the basis of results of IHC-S, per-
formed on all specimens of our cohort, we were then able to
clearly assign all cases to CE or AE. First, a panel of mac-
roscopic and microscopic features was recorded, and eval-
uated for its informative value to discriminate between CE
and AE. A summary of results including a detailed statistical
evaluation is shown in Tables 2 and 3.
The size of the entire parasitic lesion was determined
macroscopically (Fig. 2), with a median of 8.0 cm in AE,
and 9.0 cm in CE, thus showing low power to discriminate
between AE and CE. In contrast, the size of the smallest
cyst (median CE: 4.8 cm/AE: 0.1 cm), and of the largest
cyst (median CE: 8.0 cm/AE 1.15 cm), both revealed a
very good discriminative power. Thus, these parameters
can be exploited to differentiate between the two entities
(smallest cyst ≤ 2 mm and largest cyst ≤ 25 mm pointing
toward AE; smallest cyst > 2mm and largest cyst > 25
mm pointing toward CE). Likewise, the number of cysts
within a lesion can be utilized: The number of cysts was
divided into two categories: “up to 9 cysts” versus “10 and
more cysts.”Using “10 and more cysts” as an indicator for
AE, and “9 and less cysts” as an indicator for CE, showed
both high sensitivity and specificity, making the number of
cysts a powerful diagnostic test.
E. granulosus cysts include a surrounding rim of fib-
rosis, which usually is macroscopically visible as a light
beige zone (Fig. 2A). This fibrotic rim reflects the host
reaction, and is not part of the parasite tissue (Fig. 3C). The
thickness of the pericystic fibrosis (adventitial layer, AL), as
determined on elastica van Gieson stains, showed a median
of 1.10mm in the cysts of CE. In contrast, all individual E.
multilocularis metacestode vesicles were surrounded by a
lean fibrotic rim. As the lesions frequently displayed central
TABLE 2. Statistical Data Part 1: Continuous Criteria
Type of Echinococcosis Range Median AUC 95% CI Cutpoint
Thickness LL (mm) AE 0.05-0.50 0.05 0.99 0.96-1.00 ≤ 0.15
CE 0.15-2.10 0.60 > 0.15
Size of smallest cyst (cm) AE 0.10-7.00 0.10 0.97 0.93-1.00 ≤ 0.20
CE 0.10-20.00 4.80 > 0.20
Size of largest cyst (cm) AE 0.10-10.00 1.15 0.92 0.85-0.98 ≤ 2.50
CE 0.10-20.00 8.00 > 2.50
Thickness of fibrosis (mm) AE 0.00-3.00 0.30 0.89 0.80-0.96 ≤ 0.60
CE 0.00-15.00 1.10 > 0.60
Lesion size (cm) AE 1.20-20.00 8.00 0.57 0.45-0.69 —
CE 0.50-20.00 9.00 —
Criteria informative for differential diagnosis are highlighted in bold letters.
CI indicates confidence interval; AUC, area under the curve.
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necrotic areas with numerous confluent cysts and
concomitant fibrotic reaction, the thickness of individual
cysts was not measured inside the lesion, but rather in the
outer part containing intact single cysts showing a median of
0.3mm in cysts of AE (Fig. 3D). The thickness of the
pericystic fibrosis was shown to be a powerful diagnostic
criterion to differentiate between AE and CE. Infections
with both parasites induced an inflammatory reaction in the
tissue adjacent to the cystic lesions. In intact cysts, the
components, and intensity of the inflammatory infiltrate
(lymphoplasmocellular, active, follicular, foreign body
reaction, eosinophilic, generally chronic, and generally
active) showed very low sensitivity and/or specificity
(Table 3). Thus, the cellular composition of the inflammatory
reaction was not considered a criterion suitable to discriminate
between AE and CE.
Parasitic lesions in both CE and AE patients constitute
a cell-free carbohydrate-protein layer designated as LL. The
LLs of E. granulosus and E. multilocularis obviously differ
with respect to their shape and thickness (Figs. 3E, F). The
LL of E. granulosus was merely thick (median 0.6mm) and
showed a sharply demarcated striation—reminiscent of the
creasing of a vinyl—as well as a rather eosinophilic coloration
in H&E stain. In contrast, the LL of E. multilocularis
displayed a thin (median 0.05mm), in HE stain rather pale
and blueish colored membrane with no prominent creasing—
reminiscent of a watercolor painting. The morphologic
criteria “thickness of the LL” showed a very high power to
discriminate between AE and CE (a thickness ≤0.15mm
pointing toward AE/>0.15mm pointing toward CE).
Moreover, the thickness of the LL turned out to be the
single best diagnostic criterion for differentiating between the
two parasites. The striation pattern was dichotomized into 2
categories (weak striation vs. moderate-strong striation).
Using a “moderate to strong striation” as an indicator of
CE and a “weak striation” as an indicator of AE showed
high sensitivity and specificity. Thus, striation proved to be a
further diagnostically valuable criterion.
Although the presence of a nucleated GL had been re-
ported to be restricted to CE,19 we detected a GL in 50.8% of
TABLE 3. Statistical Data Part 2: Categorical Criteria
Type of Echinococcosis Diagnostic Criterion Sensitivity 95% CI Specificity 95% CI
No. cysts AE > 9 0.95 0.85-0.99 0.90 0.76-0.97
CE ≤ 9
Striation LL AE Weak 0.89 0.78-0.96 0.98 0.87-1.00
CE Moderate-strong
Vital protoscolices AE Absent 0.97 0.88-1.00 0.30 0.17-0.47
CE Present
Calcification of protoscolices AE Absent 0.95 0.86-0.99 0.05 0.01-0.17
CE Present
Calcification of LL AE Absent 0.91 0.81-0.97 0.03 0.00-0.13
CE Present
Necrosis AE Present 0.85 0.73-0.93 0.25 0.13-0.41
CE Absent
Generally chronic inflammation AE No-little 0.80 0.67-0.89 0.25 0.13-0.41
CE Much
Lymphoplasmocytic inflammation AE No-little 0.80 0.67-0.89 0.25 0.13-0.41
CE Much
Follicular inflammation AE Absent 0.76 0.63-0.86 0.25 0.13-0.41
CE Present
Calcification of pericyst AE Absent 0.69 0.55-0.80 0.20 0.09-0.36
CE Present
Calcospherites AE Present 0.63 0.49-0.75 0.85 0.70-0.94
CE Absent
Ghost protoscolices AE Absent 0.53 0.39-0.66 0.73 0.56-0.85
CE Present
General calcification AE Much 0.51 0.37-0.64 0.90 0.76-0.97
CE No-little
GL AE Absent 0.51 0.37-0.64 0.85 0.70-0.94
CE Present
Neutrophilic inflammation AE Much 0.49 0.36-0.63 0.85 0.70-0.94
CE No-little
Foreign body reaction AE Present 0.46 0.33-0.59 0.65 0.48-0.79
CE Absent
Calcification of detritus AE Absent 0.43 0.30-0.57 0.25 0.13-0.41
CE Present
Generally active inflammation AE Present 0.42 0.30-0.56 0.88 0.73-0.96
CE Absent
Eosinophilic inflammation AE Present 0.42 0.30-0.56 0.75 0.59-0.87
CE Absent
Criteria informative for differential diagnosis are highlighted in bold letters. For criteria with high specificity and/or sensitivity, the values are highlighted in bold numbers.
CI indicates confidence interval.
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AE cases. Moreover, the detectability of protoscolices in AE
had been controversially discussed.19,20,44 We detected viable
(28.3% in CE vs. 1.7% in AE, Fig. 1) and decaying (ghost)
protoscolices (70.4% in CE vs. 45.8% in AE) in both diseases.
Thus, neither the presence of a GL nor that of protoscolices
proved to be a useful diagnostic criterion.
The lesions of both Echinococcus spp. contain not
only well-defined parasitic structures, but also detritus and
antigenic remnants. In E. multilocularismetacestodes, they
have been visualized by IHC-S with the mAbEm2G11,
and designated as “SPEMS” (small particles of E. multi-
locularis).17 SPEMS were detectable not only within the
cyst but also in the liver tissue surrounding the cysts. The
SPEMS’ staining pattern was not only recapitulated with
mAbEmG3, but displayed even a stronger positivity
compared with the mAbEm2G11. Staining all of these
lesions with mAbEmG3 not only confirmed this finding,
but the staining pattern also was more pronounced
(Supplement 6A, B—Fig., Supplemental Digital Content
6, http://links.lww.com/PAS/A846). Although the LL of E.
granulosus is considered an important immune evasion
structure protecting the GL from the host’s defense,
staining of pericystic tissue with mAbEmG3 surprisingly
revealed a positive reaction in the pericystic tissue showing
small particles of E. granulosus (SPEGS; Supplement 6C—
Fig., Supplemental Digital Content 6, http://links.lww.
com/PAS/A846). We could not find any obvious difference
in the amount or intensity of pericystic antigenic material
in AE versus CE using mAbEmG3.
Besides those discussed above, further criteria were
tested as potential discriminators including necrosis, cal-
ciferous corpuscles, or calcification in pericyst/LL/proto-
scolices/necrotic debris. However, none of these proved
powerful in discriminating between CE versus AE. Using
classical ROC analysis, we identified six histologic criteria
as powerful tools discriminating between CE and AE.
These are the (i) size of smallest cyst, (ii) thickness of the
LL, (iii) size of largest cyst, (iv) striation of the LL, (v)
number of cysts, and (vi) thickness of the pericystic fib-
rosis. This was confirmed by the fitting of a random forest
using all criteria and identifying the same 6 histologic
criteria as most influential in an importance plot (Fig. 4).
Next, we sought to develop an easy to use and robust
algorithm based on the histopathologic criteria analyzed in this
study, which allows the surgical pathologist to differentiate
between CE and AE. In conjunction with serologic findings,
IHC, and genetic (PCR-based) testing, the histomorphologic
findings of our study were integrated into an algorithm that
guides the diagnosis and differential diagnosis of echino-
coccosis (Fig. 5). This approach enabled us to unequivocally
classify all cases of our cohort as either CE or AE, respectively,
including the 54 cases that before re-evaluation for this study
had been assigned as “echinococcosis NOS.” Of note,
determining the optimal tree using the six identified
histologic criteria, already a combination of only two of
these, that is, thickness of LL and thickness of pericystic
fibrosis (AL), allowed us to diagnose with an estimated
prediction accuracy of 95% in our cohort (Supplement 7—
Fig., Supplemental Digital Content 7, http://links.lww.com/
PAS/A847).
Finally, we applied the tools and the newly developed
diagnostic algorithm on difficult to diagnose cases: (1) A
55-year-old female breast cancer patient with a cystic liver
lesion suspicious of liver metastasis (Figs. 6A–C). (2) A
37-year-old male patient who presented with cystic bone
lesions of unknown nature in the lumbosacral region,
surrounded by pericystic bone destruction (Figs. 6D–F). (3)
A 78-year-old female patient with metastasizing ovarian
cancer, and an incidental finding of a cystic lesion on liver
surgery (Figs. 6G–I). Although neither histology nor initial
serologic testing was diagnostic, we were able to make the
final diagnosis of echinococcosis in all 3 cases by applying
IHC-S. Thus, combined IHC-S introduced here is useful for
reliably diagnosing (mAbEmG3) and subsequently subtyping
(mAbEm2G11) echinococcosis, particularly in clinically
unexpected cases and those with equivocal or lacking sero-
logic results.
FIGURE 2. Diagnostic criteria for differentiation of CE and AE:
macroscopy. A, Liver specimen with 2 large cysts of Echino-
coccus granulosus metacestodes. One cyst is necrotic (black
asterisk), the other presumably vital (white asterisk). Inside the
large cyst, parts of the LL are visible (white arrowhead). The
cystic lesions are surrounded by fibrous capsule (pericystic
fibrosis/AL; black arrowhead), which is produced by the host.
B, Hemihepatectomy specimen with Echinococcus multilocularis
infection revealing 2 spongy solidifications (black asterisks)
comprising conglomerates of tiny cysts (the largest marked by
the black arrowhead). Because of its small size, the LL cannot
be identified macroscopically. In contrast to CE, AE does not
show a clear-cut margin by a prominent perilesional fibrotic
zone. Scale bars: 1 cm.
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FIGURE 3. Diagnostic criteria for differentiation of CE and AE: Histology. Characteristic histologic patterns comparing CE (A) with AE (B). A, A
single larger cyst with a fibrotic rim (AL, arrowhead) and liver tissue. Inside the cyst, some parts of the LL are visible. B, Polycystic lesion with
lots of small, polymorphous, and partly conglomerated cysts. Although the center frequently is necrotic and fibrotic, the single cyst at the
periphery is not accompanied by a broad fibrous rim. Contorted parts of the LL are present in the lumina of some of the cysts. C and D,
Pericystic fibrosis. Cysts of Echinococcus granulosus metacestodes constantly display a significantly broader fibrotic capsule, known as cyst
capsule, pericyst, or AL (between the two arrowheads, elastica van Gieson stain) (C) compared with those of Echinococcus multilocularis (D).
Cyst lumina marked with an asterisk. E and F, Morphology of LL. E, Thick LL of E. granulosus cysts with a rather reddish appearance in H&E
staining with typically prominent striation. F, Lesion of E. multilocularis metacestodes with numerous small cysts, partly filled with thin
conglomerates of LL. The inset shows the thin LL with a more or less bluish-clear aspect in H&E staining, lacking a prominent striation even at
higher magnification. Note that (E) and (F) are recorded in the same magnification. Scale bars: A and B: 5mm, C and D: 500 μm, E and F:
2.5mm, all insets: 100μm.
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DISCUSSION
AE and CE, parasitic diseases with significant global
health burden, are recently increasingly recognized in many
parts of the world including North America.2,7,45 Although
the liver is the organ most affected by both CE (68.8%) and
AE (99.0%),9,10,20 the course of the diseases, their prognoses,
and patients‘ management decisively differ between the
two.10 Treatment of CE comprises a variety of approaches
including surgical procedures (pericystectomy/cystectomy,
liver segment resection etc.) combined with temporary
treatment with albendazole, percutaneous treatments to
destroy the GL or to evacuate the entire endocyst, and
mostly short-term treatment with antiparasitic drugs.20,46 In
contrast, for AE, long-term or even lifelong drug treatment
and/or radical resection in combination with a drug treat-
ment at least for 2 years are recommended.20 Thus, dis-
criminating CE versus AE is a prerequisite for the optimal
therapeutic management. Therefore, a putative diagnosis
based on imaging and serology should be confirmed by
histopathology, optionally supplemented by PCR and/or
IHC, to avoid a diagnosis of “echinococcosis, NOS.”
Thus, there is clearly a need to identify (histo-)
pathologic criteria, which allow to reliably discriminate
between CE and AE. However, a systematic and thorough
(histo-)pathologic description of echinococcosis on a sub-
stantial number of cases was still awaiting. For example, the
discrimination between CE and AE was restricted to the
differences in the number of cysts or the macroscopic
growth type.47 Moreover, the metacestode stage of
E. granulosus has been described as a slowly growing cystic
mass, in contrast to metacestode of E. multilocularis
composed of a conglomerate with a cancer-like invasive
growth.48 However, a detailed (histo-)pathologic description
of the different cyst components of both Echinococcus spp.
was lacking.
The comprehensive and statistically underpinned
analysis of a cohort of > 100 echinococcosis surgical
specimens performed in this study resulted in several find-
ings that are not in line with the current textbook knowledge
and go beyond what has been reported in previous studies.44
For example, criteria claimed to be specific for CE, that is,
fully developed protoscolices and the GL,19 were also found
in E. multilocularis metacestode tissue in our observations.
Several histopathologic changes were reported to differ
between E. granulosus and E. multilocularis lesions,19,20,47,48
FIGURE 5. A diagnostic algorithm for echinococcosis. On the
basis of clinical suspicion of echinococcosis (eg, by ultrasound
findings), the combination of the congruency of the 6 de-
picted histologic criteria and the serologic findings in most
cases can lead to the correct diagnosis. In equivocal cases, a
stepwise approach can be followed by integrating IHC, fol-
lowed by molecular testing. In case histology, IHC, and PCR
testing collectively are inconclusive, the decision has to be
made, on the basis of conventional histology, as to whether or
not there is substantial clue for echinococcosis, then denomi-
nated as “echinococcosis, NOS” versus “no proof of echino-
coccosis.”
FIGURE 4. Change of prediction accuracy. The plot shows the
mean decrease of the prediction accuracy if excluding single
assessment criteria. The first six criteria are the most valuable
ones (the most meaningful are size of the smallest cyst and
thickness of the LL). Two further criteria, that is, the detection
of calcospherites and of a granulocytic inflammatory response
have a tendency to be useful. Thus, they potentially can be
used as additional corroborative criteria. For better visual-
ization, vertical and horizontal lines separate the 6 powerful
diagnostic criteria (on the right side) from the rest, the latter
showing a lesser decrease of prediction accuracy.
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and thus proposed as discriminating criteria. However, these
studies did not include any statistical evaluation of individual
(or combined) criteria for their discriminative value. We,
here, identified six statistical validated pathologic criteria,
which allow us to confidently discriminate between CE and
AE (Tables 2, 3). Moreover, we have demonstrated already
FIGURE 6. Three challenging cases illustrating the diagnostic power of IHC. A–C, Case 1 of a 55-year-old female patient with a
history of recent breast cancer. Biopsy of a suspected liver metastasis revealing liver tissue bordered by a short fibrotic zone and
plenty of necrosis without any structured morphology (A). Strong positivity of necrotic debris for mAbEmG3 (B) and mAbEm2G11
(C), allowing to confidently diagnose the lesion as an AE. D–F, Case 2 of a 37-year-old male patient with an unclear cystic bone
lesion in the lumbosacral region. Histology (D) reveals lamellar bone tissue (asterisk), surrounded by necrotic debris (double
asterisk) and lots of thin LL (black arrowheads). Debris and LL strongly react with the mAbEmG3 (E), but not with the mAbEm2G11
(F), thus pointing to an Echinococcus granulosus infection. G–I, Case 3 of a 78-year-old female patient with metastasizing papillary
ovarian cancer. Incidental finding of a cystic liver lesion during surgery. The lesion consists of a single cyst with pericystic fibrosis,
morphologically reminiscent of an E. granulosus cyst (G, inset). Within the cysts’ lumen, numerous thin LL are detectable
(G, asterisk). LL, debris, and parts of the surrounding tissue stain strongly for mAbEmG3 (H) and mAbEm2G11 (I), indicative of AE. LL is
marked with an asterisk. Scale bars: A–C: 2.5mm, insets in A and C: 250 μm, D–F: 500 μm, G–I: 1mm, inset in G: 5mm.
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that two histopathologic criteria, that is, the thickness of the
LL and the thickness of the pericystic fibrosis of a single cyst
(AL), allowed us to discriminate between CE and AE with an
estimated prediction accuracy of 95% in our cohort
(Supplement 7—Fig., Supplemental Digital Content 7,
http://links.lww.com/PAS/A847). A central result of the
present study is the new and robust diagnostic algorithm,
which is easily applicable in daily practice to differentiate
between CE and AE. Thus, we consider already the histol-
ogy-based part of the diagnostic algorithm (Fig. 5) to be
powerful for the differentiation between CE and AE.
Another central result of the present study is the
validation of the novel mAbEmG3 directed against
Echinococcus spp. and its implementation for routine use.
The evaluation clearly documented the genus specificity of
the mAbEmG3, reacting with both structural antigens and
with cyst fluid of both Echinococcus spp. Interestingly,
mAbEmG3 reacts with mAbEm2G11 affinity purified
Em2 antigen and with E. granulosus antigens. This Echi-
nococcus spp. specificity makes the mAbEmG3 a powerful
ancillary tool in different diagnostic settings. IHC-S with
this antibody can be exploited to reliably diagnose echi-
nococcosis even in the complete or partial absence of
clearly identifiable morphologic criteria in tissue sections
—as illustrated in the cases shown in Figure 6. We
demonstrated that a combined IHC-S approach with both
antibodies is equally specific as, and occasionally even
more sensitive than, the previous gold standard of PCR-
based genetic testing. On the basis of these observations,
and given that we did not observe a single case completely
void of any immunoreactivity, we concluded that—
although a double-negative staining result cannot ulti-
mately exclude echinococcosis—it is suggestive of an un-
derlying pathology other than echinococcal infection.
Remarkably, similar to the mAbEm2G11, the mA-
bEmG3 also allowed us to detect—presumably pericystic
—decayed parasitic material, representing small particles
of E. multilocularis, the so-called “SPEMS.”17 We dem-
onstrated these antigenic particles not only in AE cases,
but also in cases of CE, indicating that “SPEMS” are not
restricted to AE. Thus, we propose to term these small
antigenic particles in CE as SPEGS. The presence of this
particular immunogenic material might not only be useful
in several diagnostic scenarios such as cytologies of aspi-
rates, but also be relevant for understanding the host’s
immune reaction against the parasite.
In summary, the present study improves our
knowledge on the histopathology of echinococcosis. We
have challenged several statements on echinococcosis,
identified robust histopathologic criteria as discriminators
between CE and AE, and introduced a highly sensitive
and specific IHC panel. We expect our findings to improve
histopathologic diagnosis, thus impacting on patients’
management of echinococcosis.
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